ACTU
Price
$1.07
Change
-$0.08 (-6.96%)
Updated
Sep 11 closing price
Capitalization
25.58M
81 days until earnings call
Intraday BUY SELL Signals
APGE
Price
$135.07
Change
-$0.01 (-0.01%)
Updated
Sep 2 closing price
Capitalization
10.22B
65 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ACTU vs APGE

ACTU vs APGE Comparison Chart in %
View a ticker or compare two or three
VS
ACTU vs. APGE commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACTU is a Hold and APGE is a Buy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APGE($10.2B) has a higher market cap than ACTU($25.6M). APGE YTD gains are higher at: 78.948 vs. ACTU (-82.516). ACTU has higher annual earnings (EBITDA): -20.43M vs. APGE (-303.65M). APGE has more cash in the bank: 1.06B vs. ACTU (4.43M). ACTU (0) and APGE (0) have equivalent revenues.
ACTUAPGEACTU / APGE
Capitalization25.6M10.2B0%
EBITDA-20.43M-303.65M7%
Gain YTD-82.51678.948-105%
P/E Ratio6.50N/A-
Revenue00-
Total Cash4.43M1.06B0%
Total DebtN/A8.05M-
TECHNICAL ANALYSIS
Technical Analysis
ACTUAPGE
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
63%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 9 days ago
90%
Bullish Trend 13 days ago
80%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend about 1 month ago
66%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 5 days ago
72%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
74%
COMPARISON
Comparison
Sep 12, 2026
Stock price -- (ACTU: $1.07 vs. APGE: $135.07)
Brand notoriety: ACTU and APGE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACTU: 43% vs. APGE: 326%
Market capitalization -- ACTU: $25.58M vs. APGE: $10.22B
ACTU [@Biotechnology] is valued at $25.58M. APGE’s [@Biotechnology] market capitalization is $10.22B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.64B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACTU’s FA Score shows that 0 FA rating(s) are green while APGE’s FA Score has 0 green FA rating(s).

  • ACTU’s FA Score: 0 green, 5 red.
  • APGE’s FA Score: 0 green, 5 red.
According to our system of comparison, APGE is a better buy in the long-term than ACTU.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACTU’s TA Score shows that 3 TA indicator(s) are bullish while APGE’s TA Score has 3 bullish TA indicator(s).

  • ACTU’s TA Score: 3 bullish, 7 bearish.
  • APGE’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, APGE is a better buy in the short-term than ACTU.

Price Growth

ACTU (@Biotechnology) experienced а -27.70% price change this week, while APGE (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Reported Earning Dates

ACTU is expected to report earnings on Dec 02, 2026.

APGE is expected to report earnings on Nov 16, 2026.

Industries' Descriptions

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
ACTU
Daily Signal:
Gain/Loss:
APGE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TRSG1.530.09
+6.25%
Tungray Technologies
VRTX515.440.88
+0.17%
Vertex Pharmaceuticals
ESCA19.51-0.20
-1.01%
Escalade
TBBB50.46-0.88
-1.71%
BBB Foods
AZUL6.85-0.21
-2.97%
AZUL SA

ACTU and

Correlation & Price change

A.I.dvisor tells us that ACTU and AGEN have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ACTU and AGEN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACTU
1D Price
Change %
ACTU100%
-6.96%
AGEN - ACTU
27%
Poorly correlated
+0.73%
TBPH - ACTU
27%
Poorly correlated
-0.06%
PDSB - ACTU
27%
Poorly correlated
-6.47%
APGE - ACTU
25%
Poorly correlated
N/A
DNA - ACTU
25%
Poorly correlated
-0.44%
More

APGE and

Correlation & Price change

A.I.dvisor indicates that over the last year, APGE has been loosely correlated with DFTX. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if APGE jumps, then DFTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APGE
1D Price
Change %
APGE100%
N/A
DFTX - APGE
50%
Loosely correlated
+3.07%
BOLD - APGE
49%
Loosely correlated
-0.35%
ORKA - APGE
48%
Loosely correlated
+0.80%
SYRE - APGE
47%
Loosely correlated
+2.13%
RCUS - APGE
39%
Loosely correlated
-5.97%
More